Print version Decrease text Increase text

LeishEpiNetSA - Control strategies for visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) in South America: applications of molecular epidemiology

EC contribution
: € 2.489.823
Duration
: 36 months
Starting date
: 01/01/2006
Funding scheme
: Specific Targeted Research Project
Keywords
: leishmaniasis, epidemiological tools, drug-resistance
Contract/Grant agreement number
: 015407
Project web-site
: under construction

Background:

Molecular epidemiology and population genetics can resolve the diversity and structure of Leishmania populations, for example the intricate relationships between clinical forms of human infection and mammal reservoirs. Research will involve comparative investigations between endemic areas for VL and MCL in Paraguay, Peru, Brazil and Venezuela and will strengthen local capacities for research and for Latin American-European collaborations. The technical aim is to develop a full range of microsatellite markers and multi-locus sequencing typing (MLST) of housekeeping genes for the Leishmania braziliensis complex and for L guyanensis. We will also establish in South America the procedures for microsatellite and MLST analysis for L. infantum, which have been developed and proven as epidemiological tools by a European network. The practical aims are to encourage the application of these and other molecular epidemiological methods in South America for 1. elucidating parasite-vector-host relationships 2. assessing the epidemiological impact of VL-HIV co-infection (Brazil) 3. assessing the epidemiological importance of recombinant Leishmania genotypes and 4. assessing the spread of resistance against first line treatment (SbV). In addition, we will compare genotypes of a) Leishmania isolated from diverse clinical cases of leishmaniasis and b) drug susceptible and drug-resistant strains. The project will be undertaken in the context of an investigation of present understanding and intervention strategies among health professionals, defining how best to introduce project outputs into improved control. An accessible South American repository for Leishmania will be established, incorporating an existing collection, new isolates and representatives from other endemic regions.


Problem:

The Leishmania are single-celled parasites, which cause diseases of humans and dogs and are transmitted by sand flies. In South America, the subgenus Viannia causes cutaneous (CL) or severe mucocutaneous leishmaniasis (MCL). In Europe and South America, L. (L.) infantum causes fatal visceral leishmaniasis (VL). A full and detailed understanding of the transmission cycles and molecular epidemiology of visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) is necessary to develop disease control and surveillance.

Aim:

The overall aim of this project is to apply molecular methods to improve understanding of the epidemiology of the subgenus Viannia and L. infantum in South America.

Expected and obtained results:

A range of new epidemiological tools will be produced. Detailed insight will be gained into the comparative epidemiology of CL, MCL and VL in South America. Distribution of drug-resistant genotypes will be mapped. A wealth of data will be deposited in a new database, linked to a European database. An expanded South American repository for Leishmania will be established, with new isolates and representatives from other endemic regions. Local capacities for research and for Latin American -European collaborations will be strengthened. Cooperation will be improved between South American researchers. A strong South American/European network will be established, with active, shared and synergistic research objectives, multiway collaborations and exchanges. A cohort of individuals will be trained and technologies will be transferred between the partners. A series of publications and reports will be written to disseminate findings from the project. Recommendations will be made on more cost-effective methods for identifying genetic groups of Leishmania.

Potential applications:

Improved strategies for surveillance and control, with consequent benefits to public health and the alleviation of poverty.

Coordinator:

Prof. Michael A. Miles
London School of Hygiene and Tropical Medicine
Department of Infectious and Tropical Diseases
Keppel Street
London WC1E 7HT
England, UK
Tel. +44 2079272340
E-mail: michael.miles@lshtm.ac.uk

Partners:

Dr Gabriele Schoenian
Charite Universitaetsmedizin Berlin
Berlin, Germany

Dr Carmen Canavate
Instituto de Salud Carlos III
Madrid, Spain

Dr Jean-Claude Dujardin
Prinz Leopold Instituut voor Tropische Geneeskunde
Antwerp, Belgium

Dr Lenea Campino
Universidade Nova de Lisboa/Instituto de Higiene e Medicina Tropical
Lisbon, Portugal

Dr Semiramis do Monte
Centro de Ciencias da Saude da Universidade Federal do Piaui
Teresina, Piaui, Brazil

Dr Rolando Oddone
Universidad Nacional de Asunción
Asunción, Paraguay

Dr Jorge Arevalo
Universidad Peruana Cayetano Heredia
Lima, Peru

Dr Maria Norma Melo
Universidade Federal de Minas Gerais
Belo Horizonte, Brazil

Prof. Maria Dora Feliciangeli
Universidad de Carabobo-Centro de Investigaciones Biomedicas
Caracas, Venezuela

Dr Elisa Cupolillo
Sociedade de Promoção da Casa de Oswaldo Cruz
Rio de Janeiro, Brazil

Dr Joachim Clos
Bernhard Nocht Institute for Tropical Medicine
Hamburg, Germany